Case number 1:17-cv-00113
Amgen Inc. v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 19, 2020 | N/A | Terminated Case (0) |
| Mar 14, 2018 | 16 | Stipulation of Dismissal (1) |
| Mar 14, 2018 | 16 | Patent/Trademark Report to Commissioner (1) |
| Feb 28, 2018 | 15 | Stipulation of Dismissal (1) |
| Feb 6, 2018 | 14 | Order Reassigning Case (1) |
| Sep 27, 2017 | 13 | Notice of Service (2) |
| Aug 18, 2017 | 12 | Notice (Other) (3) |
| Aug 1, 2017 | N/A | CORRECTING ENTRY: (0) |
| Mar 10, 2017 | N/A | CORRECTING ENTRY: (0) |
| Mar 3, 2017 | N/A | CORRECTING ENTRY: (0) |
| Feb 23, 2017 | N/A | Remark (0) |
| Feb 23, 2017 | N/A | Scheduling Conference (0) |
| Feb 22, 2017 | 9 | Answer to Complaint (14) |
| Feb 22, 2017 | 10 | Disclosure Statement (3) |
| Feb 22, 2017 | 11 | Order (2) |
| Feb 8, 2017 | N/A | Case Assigned/Reassigned (0) |
| Feb 6, 2017 | 6 | Notice of Appearance (1) |
| Feb 6, 2017 | 6 | Notice of Appearance (1) |
| Feb 6, 2017 | 1 | Main Document (10) |
| Feb 6, 2017 | 5 | Disclosure Statement (1) |
| Feb 6, 2017 | 2 | Civil Cover Sheet (3) |
| Feb 6, 2017 | 1 | Exhibit A (14) |
| Feb 6, 2017 | 8 | Summons Returned Executed (2) |
| Feb 6, 2017 | 7 | Summons Returned Executed (2) |
| Feb 3, 2017 | 4 | Patent/Trademark Report to Commissioner (1) |
| Feb 3, 2017 | 3 | ANDA Form (1) |
| Feb 3, 2017 | 2 | Magistrate Consent Forms (3) |
| Feb 3, 2017 | 1 | Civil Cover Sheet (3) |
| Feb 3, 2017 | 1 | Complaint (10) |
| Feb 3, 2017 | N/A | Summons Issued (0) |
| Feb 3, 2017 | 1 | Complaint* (1) |
